Jason Clarke, University of Michigan, Department of Pediatrics, Division of Nephrology November 5, 2003
Potter’s Syndrome
History
In 1946 Edith Louise Potter (b.1901 – d.1991), a pediatric pathologist at the University of Chicago Lying-In Hospital, described anomalies of the fetus due to oligohydramnios1. The condition itself has been documented since the late 17th century and was considered to be an extremely rare condition. In one of her more famous manuscriptsa, Potter analyzed approximately 5000 necropsies2 performed on fetuses and newborn infants over a period of ten years, and found that 20 infants presented with bilateral3 renal4 agenesis5 (BRA) (1:250)*. From her studies she was able to deduce the sequence of events that leads to what is now known as Potter’s Syndrome, Potter’s Sequence6, or Oligohydramnios Sequence. As well as to accurately describe and assign facial characteristics of the affected, which are known as Potter’s facies7.
Since its initial characterization, Potter’s Syndrome has been defined into five distinct subclassifications. Classic Potter’s Syndrome occurs when the infant has bilateral renal agenesis. True BRA also presents with bilateral agenesis of the ureters8. Potter’s Syndrome Type I is due to Autosomal9 Recessive10 Polycystic Kidney Disease11 (ARPKD), which occurs at a frequency of approximately one in 40,000 infants and is due to a mutation12 in the gene PKD1. Potter’s Syndrome Type II is due to Renal Adysplasia13 (RA), which can also fall under the category known as hereditary renal adysplasia (HRA). Potter’s Syndrome Type III is due to Autosomal Dominant14 Polycystic Kidney Disease (ADPKD) due to a mutation in the gene PKD2. Potter’s Syndrome Type IV occurs when a longstanding obstruction in either the kidney or ureter leads to cystic kidneys. This can be due to chance, environment, or genetics. In all five instances, a lack or reduced volume of fetal urine typically leads to oligohydramnios and results in the physical deformities and prognosis described below.
*
This statistic (of one in 250) does not imply that Classic Potter’s Syndrome occurs in one out of 250 infants. This statistic was obtained from a study published in 1946 of 5000 expired infants that were allowed or obligated to be subjected to a routine or requested autopsy or necropsy.a
In this context, a manuscript is a peer reviewed and formally published article in a scientific journal describing the research methods and obtained results, as well the hypotheses from a study.
Classic Potter’s Syndrome
Classic Potter’s Syndrome occurs when the developing fetus has bilateral renal agenesis, which also presents with ureteral agenesis15 (UA). BRA has been estimated to occur at a frequency of approximately 1:5000 infants. However, recent analysis has estimated that the condition may occur at a much greater frequency. The condition has been reported to occur twice as common in males as in females, suggesting that certain genes of the Y chromosome16 may act as modifiers17. However, no candidate genes on the Y chromosome have yet been identified. BRA appears to have a predominantly genetic etiology18 and many cases represent the most severe manifestation of an autosomal dominant condition with incomplete penetrance19 and variable expressivity20. There are several genetic pathways that could result in this condition. To date, few of these pathways or candidate genes have been considered or analyzed regarding this specific syndrome. The majority of possible pathways are autosomal recessive in nature and do not coincide with the frequency or penetrance at which BRA occurs. Additionally, candidate pathways would be expected to involve genes expressed in the developing urogenital system21 (UGS). Often, these same genes and/or pathways of interacting genes are expressed in the developing UGS and also expressed in the Central Nervous System22 (CNS), gut, lung, limbs, and eyes. This often makes it difficult to say with complete certainty that these genes are responsible for a predominantly renal disease.
Normal kidney development
In humans, the metanephros23 is detectable by the fifth gestational week as two small areas in the mesoderm24 close to the pelvic aorta25. It is approximately at this time that the nephric duct26 produces a ureteric bud27 that has, or will soon invade the aggregate of cells known as the metanephric mesenchyme28. The ureteric bud is stimulated by genetic signals emanating from the metanephric mesenchyme, and brings with it new genetic signals that will help the kidney form. The ureteric bud will grow into, and branch several times within, the metanephric mesenchyme. Eventually, the ureteric bud will form the collecting ducts and the ureters. The primitive nephric duct will degenerate to some degree, but portions of it will go on to form the correct gender specific organs. The ureteric bud, once it has invaded, stimulates certain cells within the metanephric mesenchyme to condense around the tips of the branches of the ureteric bud within the metanephric mesenchyme, and eventually form nephronic units29. In humans, all of the branches of the ureteric bud and the nephronic units have been formed by 32 to 36 weeks of gestation. However, these structures are not yet mature, and will continue to mature after birth. Once matured, humans have been estimated to possess approximately one million nephronic units (approximately 500,000 per kidney). The lower portions of the ureteric bud will migrate downward, and connect with the bladder, forming the ureters. The ureters will carry urine to the bladder for excretion within the amniotic sac. As the fetus develops, the torso30 elongates and the kidneys migrate upwards, which causes the length of the ureters to increase. The development of the kidney is critical to the development of the fetus by the means of urine production. A large proportion of the amniotic fluid that surrounds the fetus is comprised of fetal urine. The amniotic fluid serves many functions to the developing fetus. It is responsible for cushioning the fetus and preventing the uterus from compressing it, thereby allowing adequate space for the fetus to properly grow. Also, the pressure of the amniotic fluid is critical to the growth, formation and expansion of the alveolar sacs31 in the developing lungs.
Phenotypes32 of Classic Potter’s Babies
The failure of the metanephros to develop in cases of BRA and some cases involving unilateral33 renal agenesis is due primarily to the failure of the nephric duct to produce a ureteric bud capable of inducing34 the metanephric mesenchyme. The failed induction will thereby cause the subsequent degeneration of the metanephros by apoptosis35 and other mechanisms. The nephric duct(s) of the agenic kidney(s) will also degenerate and fail to connect with the bladder. Therefore, the means by which the fetus produces urine and transports it to the bladder for excretion into the amniotic sac36 has been severely compromised (in the cases of URA), or completely eliminated (in the cases of BRA). The decreased volume of amniotic fluid causes the growing fetus to become compressed by the uterus. This compression can cause many physical deformities of the fetus, most common of which is Potter’s facies37. Lower extremity anomalies are frequent in these cases, which often presents with clubbed feet and/or bowing of the legs. Sirenomelia38, which occurs approximately in 1:45,000 births (Banerjee A, 2003; Indian J Pediatr) can also present. In fact, nearly all patients reported with sirenomelia have BRA (Siegel MJ, 2000; J Peri), suggesting that sirenomelia is due mainly as a result of BRA or RA. Other anomalies of the Classic Potter’s Infant include a parrot beak nose39, redundant skin40, and the most common characteristic of infants with BRA which is a skin fold of tissue extending from the medial canthus41 across the cheek. The adrenal glands42 often appear as small oval discs pressed against the posterior (back) abdomen, due to the absence of upward renal pressure43. The bladder is often small, nondistensible44 and may be filled with a minute amount of fluid. In males the vas deferens45 and seminal vesicles46 may be absent, while in females the uterus and upper vagina may be absent. Other abnormalities include anal atresia47, absence of the rectum and sigmoid colon48, esophageal49 and duodenal50 atresia, and a single umbilical artery. Additionally, the alveolar sacs of the lungs fail to properly develop as a result of the reduced volume of amniotic fluid. Labor is often induced between 22 and 36 weeks of gestation (however, in some cases the pregnancy may go to term) and unaborted infants typically survive for only a few minutes to a few hours. These infants will eventually expire as either a result of pulmonary hypoplasia51 or renal failure.
To date, Classic Potter’s Syndrome has proved to be 100% lethal in all cases. Various other forms of the syndrome are, or are near, 100% lethal. Additionally, no genetic mutation, disease, condition, or anomaly has been linked to be the cause of Classic Potter’s Syndrome.
Definitions of medical terminology
a
Heterozygous (Hetero-, different, or other) refers to the two forms of the same gene (normal and abnormal). Each person carries two copies of a gene (one from their mother and one from their father). A person that carries one normal form of the gene and one abnormal form of a gene is considered to be a heterozygous carrier (as in only one copy, out of two, of the gene is normal. The phenotype of the heterozygous carrier may be determined by either one, or both of the alleles. However, because the normal form of the gene is dominant (in an autosomal recessive instance), heterozygous carriers of a recessively abnormal gene are typically quite normal.b
An allele is one of the several alternative forms of a gene occupying a certain location on a chromosome (locus). As genes may naturally change their sequence due to evolution or other mechanisms, a gene, when naturally occupying its correct location on a chromosome is called an allele.c
Homozygous (Homo-, same or equal) also refers to the two forms of the same gene. Homozygous in genetic terms means that both the copies of the gene are the same, both are normal, or both are abnormal.
Example of Autosomal Recessive Inheritence
Let’s say that "gene A" is responsible for growing your eyebrow hair. "A" is the normal form of "gene A" and "a" is the abnormal form of "gene A." The mother and father of the family in the chart are heterozygous carriers for "gene A." Let’s suppose that as long as a person has one normal form of "gene A" they will be able to grow eyebrows. Additionally, let’s simplify matters by saying that all of the children were conceived at the same time (quadruplets).
|
Mother |
Father |
|||||
|
A a |
A a |
|||||
|
|
|
|||||
|
|
|
|||||
|
|
|
|
Children |
|
|
|
|
|
|
|
||||
|
1 |
2 |
3 |
4 |
|||
|
|
|
|
||||
AA Aa aA aa
Child 1 is normal for "gene A", and is not a carrier of the disease (Absent eyebrow syndrome) as he has received one normal form of "gene A" from mom and one from dad. There is a 25% chance of this happening. Child 1 will have very healthy eyebrows. Child 2 is heterozygous for "gene A." He received the normal form from mom and the abnormal form from dad. This child will have normal looking eyebrows but is a carrier. Child 3 is also heterozygous for "gene A," but in this case he received the normal form of the gene from dad and the abnormal form from mom. This child will also have normal eyebrows and is also a carrier. Child 4 is homozygous for "gene A," having inherited an abnormal form from mom and an abnormal form from dad. There is a 25% chance of this happening, and this child will not have any eyebrows, and, is considered to be affected. The overall statistical picture of these children is, 75% unaffected (having eyebrows) and 25% affected (not having eyebrows). However, in the real world each child individually has a one in four chance of being affected, and a one in two chance of being a heterozygous carrier.
Example of Autosomal Dominant Inheritence
Let’s use "gene B" this time and say that as long as a person has both normal forms of the gene "BB,"
their eyebrows won’t fall off when they’re 55 years old. But, if they have one abnormal form of the gene "Bb" or two abnormal forms "bb," their eyebrows will fall off on their 55th birthday. The mother and father of the family in the chart are affected heterozygous carries of the gene, but they’re only 30 years old, so they don’t know that they are carriers yet. But, in 25 years, their eyebrows will fall off!
|
Mother |
Father |
|||||
|
Bb |
Bb |
|||||
|
|
|
|||||
|
|
|
|||||
|
|
|
|
Children |
|
|
|
|
|
|
|
||||
|
1 |
2 |
3 |
4 |
|||
|
|
|
|
||||
BB Bb bB bb
Child 1 is lucky! He received a normal gene from mom and a normal gene from dad. He will not lose his eyebrows when he turns 55 and is not an affected carrier of the abnormal gene. However, Child 2 and Child 3 are affected heterozygous carriers for the abnormal gene. Their eyebrows will fall out when they turn 55, and each child has a 50% chance of passing the abnormal gene on to their children. Child 4 is definitely affected as he is a homozygous carrier for the abnormal gene. Unfortunately, this child has a 100% chance of passing the abnormal gene on to his children.
23. Metanephros: Meta-, after, or beyond. Nephr-, of or pertaining to the kidney. Therefore, metanephros refers to the kidney after a time point which normal development of the kidney should have occurred. Otherwise known as the adult or permanent kidney.
This synopsis, to include the definitions of medical terminology, is intended be an informative tool for those seeking more information about Potter’s Syndrome. The author has given the NPSSG permission to distribute this synopsis as it sees fit.